{"id":"https://openalex.org/W4409691237","doi":"https://doi.org/10.1158/1538-7445.am2025-1159","title":"Abstract 1159: Preclinical characterization of a novel STEAP1 antibody-drug conjugate ADRX-0405 for the treatment of mCRPC","display_name":"Abstract 1159: Preclinical characterization of a novel STEAP1 antibody-drug conjugate ADRX-0405 for the treatment of mCRPC","publication_year":2025,"publication_date":"2025-04-21","ids":{"openalex":"https://openalex.org/W4409691237","doi":"https://doi.org/10.1158/1538-7445.am2025-1159"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2025-1159","doi":"https://doi.org/10.1158/1538-7445.am2025-1159","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-1159","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058958167","display_name":"Maria Shahmoradgoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Shahmoradgoli","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111593786","display_name":"Andrew M. Hau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew M. Hau","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053795977","display_name":"Oscar Betancourt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oscar Betancourt","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102634046","display_name":"Felipe Acosta","orcid":"https://orcid.org/0009-0003-7198-1520","observed_orcids":["https://orcid.org/0009-0003-7198-1520"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felipe Acosta","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108910895","display_name":"Sam Janssen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sam Janssen","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109694498","display_name":"Paul Datta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Datta","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040537149","display_name":"Anna Y. Wang","orcid":"https://orcid.org/0000-0001-5075-9187","observed_orcids":["https://orcid.org/0000-0001-5075-9187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Y. Wang","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111152306","display_name":"Peter P. Challita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter P. Challita","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001861353","display_name":"K.\u2013M. Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kris Zhang","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071651766","display_name":"Mario Meng-Chiang Kuo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario M- Kuo","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094221911","display_name":"Albert Goldson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albert Goldson","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113149590","display_name":"Erin Nye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin Nye","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094219650","display_name":"Alexis Mahloch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexis Mahloch","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maojun Guo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maojun Guo","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081884994","display_name":"Alexander Chu-Kung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Chu-Kung","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115595345","display_name":"Dong Jun Lee","orcid":"https://orcid.org/0009-0008-2286-6135","observed_orcids":["https://orcid.org/0009-0008-2286-6135","https://orcid.org/0000-0002-7680-6460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong Jun Lee","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100423868","display_name":"Hui Li","orcid":"https://orcid.org/0000-0002-2108-0201","observed_orcids":["https://orcid.org/0000-0002-2108-0201","https://orcid.org/0000-0002-8743-7146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui Li","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038025135","display_name":"Sabine Rottmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabine Rottmann","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053396315","display_name":"Pia M. Challita-Eid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pia M. Challita-Eid","raw_affiliation_strings":["Adcentrx Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adcentrx Therapeutics, Inc., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":"8_Supplement_1","first_page":"1159","last_page":"1159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/steap1","display_name":"STEAP1","score":0.984000027179718},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9810000061988831},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/topoisomerase-inhibitors","display_name":"topoisomerase inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cleavable-linkers","display_name":"cleavable linkers","score":0.9120000004768372},{"id":"https://openalex.org/keywords/drug-to-antibody-ratio","display_name":"drug-to-antibody ratio","score":0.8259999752044678},{"id":"https://openalex.org/keywords/bystander-effect","display_name":"bystander effect","score":0.7490000128746033},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.8460000157356262},{"id":"https://openalex.org/keywords/pd-l1-upregulation","display_name":"PD-L1 upregulation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/deruxtecan","display_name":"deruxtecan","score":0.6919999718666077},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7424242496490479},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6383369565010071},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5470309257507324},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5428782105445862},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5405271649360657},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3784700930118561},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36393648386001587},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.17238041758537292},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15335828065872192},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0545421838760376},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2025-1159","doi":"https://doi.org/10.1158/1538-7445.am2025-1159","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-1159","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2143004018","https://openalex.org/W2330362314","https://openalex.org/W2435669318","https://openalex.org/W1995639836","https://openalex.org/W2103568534","https://openalex.org/W2057862416","https://openalex.org/W2754988198","https://openalex.org/W1543576583","https://openalex.org/W2893386726","https://openalex.org/W4214766446"],"abstract_inverted_index":{"Abstract":[0],"Prostate":[1,43],"cancer":[2,21,177],"remains":[3,24],"a":[4,25,46,86,99,107,113,117,124,161,186,219,244,272,286,323,371,455],"leading":[5],"cause":[6],"of":[7,17,35,41,85,93,106,127,146,175,190,205,211,216,228,240,246,303,338,389,454,464,469],"mortality":[8],"in":[9,14,52,62,71,77,140,149,154,169,172,297,341,355,366,396],"men.":[10],"Despite":[11],"significant":[12],"advances":[13],"the":[15,42,91,304,329,336,367,376,383,462,470],"treatment":[16,30,235,463],"metastatic":[18,72],"castration-resistant":[19],"prostate":[20,57,176],"(mCRPC),":[22],"there":[23],"need":[26],"for":[27,289,375,461,473],"more":[28],"durable":[29],"options":[31],"with":[32,59,95,142,178,193,261,281,402],"improved":[33,301,347],"quality":[34],"life.":[36],"STEAP1":[37,67,195,324,457],"(Six-Transmembrane":[38],"Epithelial":[39],"Antigen":[40],"1)":[44],"is":[45,69,98,370,404],"validated":[47],"tumor-associated":[48],"antigen,":[49],"highly":[50],"expressed":[51,75],"various":[53],"solid":[54],"tumors,":[55],"including":[56],"cancer,":[58],"restricted":[60],"expression":[61,68,196,242],"normal":[63,309,344],"tissues.":[64],"Most":[65],"noteworthy,":[66],"sustained":[70],"sites":[73],"and":[74,119,137,151,181,231,311,318,386],"even":[76],"PSMA-negative":[78],"patients,":[79],"thus":[80,284],"potentially":[81],"providing":[82,285],"an":[83,200],"opportunity":[84],"targeted":[87],"therapeutic":[88],"approach":[89],"to":[90,112,167,238,259,306,322,327],"majority":[92],"patients":[94],"mCRPC.":[96,397],"ADRX-0405":[97,130,159,198,212,234,270,351,390,403,460],"novel":[100,118,456],"STEAP1-targeting":[101],"antibody-drug":[102,458],"conjugate":[103,459],"(ADC),":[104],"consisting":[105],"humanized":[108],"IgG1":[109],"antibody":[110,325],"conjugated":[111,326],"topoisomerase":[114,221,255,377],"inhibitor":[115,378],"via":[116],"stable":[120],"cleavable":[121],"linker":[122],"at":[123],"drug-to-antibody":[125],"ratio":[126,337],"8":[128],"(DAR8).":[129],"specifically":[131],"binds":[132],"STEAP1,":[133],"induces":[134],"H2AX":[135],"phosphorylation":[136],"PARP":[138,268,282],"cleavage":[139],"line":[141],"its":[143,214,315,393],"payload":[144,294,305,340,379],"mechanism":[145,215],"action,":[147],"resulting":[148],"nanomolar":[150],"target-dependent":[152],"cytotoxicity":[153],"tumor":[155,277,342],"cells.":[156],"In":[157,185,381],"addition,":[158],"exhibits":[160],"potent":[162],"bystander":[163],"activity,":[164],"which":[165,369],"translates":[166],"robust":[168],"vivo":[170],"efficacy":[171,385],"xenograft":[173],"models":[174],"both":[179],"high":[180],"low":[182],"target":[183],"expression.":[184],"mouse":[187],"clinical":[188,290,394],"trial":[189],"patient-derived":[191],"xenografts":[192],"varying":[194],"levels,":[197],"achieved":[199],"overall":[201],"response":[202],"rate":[203],"(ORR)":[204],"83%.":[206],"Detailed":[207],"PD":[208],"characterization":[209,453],"study":[210,296,401],"confirms":[213],"action":[217],"as":[218,243,254,267,333],"DNA":[220,250,262],"inhibitor,":[222],"inducing":[223],"apoptosis":[224],"through":[225],"increased":[226],"levels":[227],"cleaved":[229],"caspase-3":[230],"pH2AX.":[232],"Notably,":[233],"also":[236],"leads":[237],"upregulation":[239],"PD-L1":[241],"result":[245],"immunogenic":[247],"cell":[248],"death.":[249],"damage":[251,263],"inducers":[252],"such":[253,266],"inhibitors":[256,265],"are":[257],"known":[258,372],"synergize":[260],"repair":[264],"inhibitors.":[269],"exhibited":[271],"strong":[273],"synergistic":[274],"effect":[275],"on":[276],"growth":[278],"when":[279],"combined":[280],"inhibitors,":[283],"compelling":[287],"rationale":[288],"combination":[291],"opportunities.":[292],"A":[293,398],"distribution":[295],"tumor-bearing":[298],"mice":[299],"demonstrated":[300],"delivery":[302],"tumors":[307],"over":[308,343],"tissues":[310,345],"plasma":[312],"driven":[313],"by":[314,335,348],"excellent":[316],"stability":[317],"PK":[319],"profile.":[320],"Compared":[321],"deruxtecan,":[328],"estimated":[330],"safety":[331,373,387],"margin":[332],"determined":[334],"free":[339],"was":[346,352,364],"2-3-fold.":[349],"Consequently,":[350],"well":[353],"tolerated":[354],"non-human":[356],"primates":[357],"repeat-dose":[358],"toxicology":[359],"evaluation.":[360],"Strikingly,":[361],"no":[362],"toxicity":[363],"detected":[365],"lungs,":[368],"liability":[374],"class.":[380],"summary,":[382],"preclinical":[384],"profile":[388],"strongly":[391],"supports":[392],"evaluation":[395],"phase":[399],"1a/b":[400],"initiated.":[405],"Citation":[406],"Format:":[407],"Maria":[408],"Shahmoradgoli,":[409],"Andrew":[410],"M.":[411,450],"Hau,":[412],"Oscar":[413],"Betancourt,":[414],"Felipe":[415],"Acosta,":[416],"Sam":[417],"Janssen,":[418],"Paul":[419],"Datta,":[420],"Anna":[421],"Y.":[422],"Wang,":[423],"Peter":[424],"P.":[425],"Challita,":[426],"Kris":[427],"Zhang,":[428],"Mario":[429],"M-":[430],"Kuo,":[431],"Albert":[432],"Goldson,":[433],"Erin":[434],"Nye,":[435],"Alexis":[436],"Mahloch,":[437],"Maojun":[438],"Guo,":[439],"Alex":[440],"Chu-Kung,":[441],"Dong":[442],"Jun":[443],"Lee,":[444],"Hui":[445],"Li,":[446],"Sabine":[447],"Rottmann,":[448],"Pia":[449],"Challita-Eid.":[451],"Preclinical":[452],"mCRPC":[465],"[abstract].":[466],"In:":[467],"Proceedings":[468],"American":[471],"Association":[472],"Cancer":[474,491],"Research":[475],"Annual":[476],"Meeting":[477],"2025;":[478],"Part":[479],"1":[480],"(Regular":[481],"Abstracts);":[482],"2025":[483],"Apr":[484],"25-30;":[485],"Chicago,":[486],"IL.":[487],"Philadelphia":[488],"(PA):":[489],"AACR;":[490],"Res":[492],"2025;85(8_Suppl_1):Abstract":[493],"nr":[494],"1159.":[495]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2025-10-10T00:00:00"}